AUG 20, 2026 · PHASE 2 TRIAL
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
ClinicalTrials.gov
This is an active Phase 2 trial registration with no results reported; it describes a planned study of asciminib in pediatric Ph+ CML, a population lacking established efficacy and safety data.
Reported
Planned enrollment50
Study phasePhase 2
Primary outcome measureMMR (major molecular response) at Week 48